G679-0175 Screening compound: 6-(4-methylphenyl)-2-[(5-{[2-oxo-2-(1,2,3,4-tetrahydroquinolin-1-yl)ethyl]sulfanyl}-1,3,4-oxadiazol-2-yl)methyl]-2,3-dihydropyridazin-3-one

G679-0175 Screening compound: 6-(4-methylphenyl)-2-[(5-{[2-oxo-2-(1,2,3,4-tetrahydroquinolin-1-yl)ethyl]sulfanyl}-1,3,4-oxadiazol-2-yl)methyl]-2,3-dihydropyridazin-3-one
G679-0175 Screening compound: 6-(4-methylphenyl)-2-[(5-{[2-oxo-2-(1,2,3,4-tetrahydroquinolin-1-yl)ethyl]sulfanyl}-1,3,4-oxadiazol-2-yl)methyl]-2,3-dihydropyridazin-3-one alternative view

Chemical Structure Depiction of ChemDiv screening compound G679-0175
6-(4-methylphenyl)-2-[(5-{[2-oxo-2-(1,2,3,4-tetrahydroquinolin-1-yl)ethyl]sulfanyl}-1,3,4-oxadiazol-2-yl)methyl]-2,3-dihydropyridazin-3-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G679-0175

Molecular Formula

C25H23N5O3S (C25 H23 N5 O3 S)

Compound Name

6-(4-methylphenyl)-2-[(5-{[2-oxo-2-(1,2,3,4-tetrahydroquinolin-1-yl)ethyl]sulfanyl}-1,3,4-oxadiazol-2-yl)methyl]-2,3-dihydropyridazin-3-one

IUPAC name

6-(4-methylphenyl)-2-[(5-{[2-oxo-2-(1234-tetrahydroquinolin-1-yl)ethyl]sulfanyl}-134-oxadiazol-2-yl)methyl]-23-dihydropyridazin-3-one

SMILES

Cc(cc1)ccc1C(C=C1)=NN(Cc(o2)nnc2SCC(N(CCC2)c3c2cccc3)=O)C1=O

InChI

InChI=1S/C25H23N5O3S/c1-17-8-10-18(11-9-17)20-12-13-23(31)30(28-20)15-22-26-27-25(33-22)34-16-24(32)29-14-4-6-19-5-2-3-7-21(19)29/h2-3,5,7-13H,4,6,14-16H2,1H3

InChI Key

MANFZYLTQJBSEW-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27150911

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

473.56

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

3.504

Distribution Coefficient, logD

3.504

Water Solubility, LogSw

-3.68

Polar Surface Area

73.367

Acid Dissociation Constant (pKa)

18.93

Base Dissociation Constant (pKb)

1.24

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

24.00

G679-0175 in Drug Discovery

Included in Screening Libraries

Angiogenesis library (14822 compounds)

Antiviral Library (67538 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

Targeted Diversity Library (40567 compounds)

Peptidomimetic Library (37031 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Antiviral
  • Infections
  • Immune system
Mechanism of action:
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Mimetics

References: we are preparing a list of scientific research reports with G679-0175 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G679-0175?
Check Price and Availability of G679-0175, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G679-0175 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G679-0175
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G679-0175
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G679-0175 available by request